跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TOBRAMYCIN CH tobramycin 300 mg/5 mL inhalation solution ampoule - TGA Drug Approval Details
Approvals
/
TGA
/
TOBRAMYCIN CH tobramycin 300 mg/5 mL inhalation solution ampoule
Approved
STANDARD
TOBRAMYCIN CH tobramycin 300 mg/5 mL inhalation solution ampoule
Juno Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
038e3f1e002ee460
Company
Juno Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
038e3f1e002ee460
Product Name
TOBRAMYCIN CH tobramycin 300 mg/5 mL inhalation solution ampoule
Artg Id
241212
Artg Name
TOBRAMYCIN CH tobramycin 300 mg/5 mL inhalation solution ampoule
Sponsor
Juno Pharmaceuticals Pty Ltd
Company Detail Path
/organization/juno-pharmaceuticals-pty-ltd
Artg Date
2016-04-13
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
038e3f1e002ee460
Type
Standard
Back to TGA Approvals
